PSI Opens New Italian Office
Today, PSI CRO, a full-service contract research organization, announced opening of a new operational office in Italy.
Today, PSI CRO, a full-service contract research organization, announced opening of a new operational office in Italy. The Italian office further expands PSI’s well-established presence in Europe and strengthens PSI’s ability to deliver global clinical trials. The PSI CRO Italy S.r.l. office is located just outside Milan at Via Badia n.55, 20060 Gessate. It will give PSI the location and support to continue attracting and recruiting top talent in the industry.
PSI has been placing clinical trials in Italy for a number of years on behalf of pharmaceutical and biotech sponsors. They have gained extensive knowledge and experience with local investigative sites in the areas of oncology, haematology, haemophilia, acute care, infectious diseases, CNS, diabetes, and other therapeutic areas.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
